Profacgen’s Scientists excel in the development and implementation of in process and release assays for biological therapeutic manufacture. In addition, Profacgen strategically utilizes well-known CTOs as key subcontractors for select specialized analysis (e.g. cell bank characterization, viral clearance studies) when such services are more effectively outsourced. This combination puts us in the unique position to not only have the skill and services necessary for assay development and support, but also the means to provide these assays in the most cost and time efficient manner.
E. coli such as improved solubility, ability to incorporate
post-translational modifications, and higher yields for secreted proteins. Its Profacgen recommends its customers to leverage sophisticated BacuFlex™ Platform to explore different
conditions for the expression of target proteins.
No comments:
Post a Comment